baber/WOPTO huggingface dataset:
Patent CA-2637701-A1 (CA)
Title: Food product comprising a proline specific protease, the preparation thereof and its use for degrading toxic or allergenic gluten peptides
Inventor: DE DECKERE EMILE
IPC: A23L23/00
Filed: 2007-01-30
Abstract: The present invention relates to a pasteurized food product having a water activity of at least 0.80, preferably at least 0.85 and containing a proline specific protease.
Patent CA-2638700-A1 (CA)
Title: Fluorescent lamp tube
Inventor: FOO ONN FAH
IPC: H01J61/30
Filed: 2008-08-15
Abstract: The present invention relates to a new type of fluorescent lamp tube for illumination, comprising lamp filaments arranged respectively at both ends of the fluorescent lamp tube; tube end portions in which the lamp filaments are enclosed respectively; and a tube portion interconnecting the tube end portions and having a diameter smaller than that of the tube end portions. The present invention breaks through the prior art, such that the lamp tube can be devised to be more compact, whereby realizing a T1-type hot cathode fluorescent lamp.
Patent CA-2638743-A1 (CA)
Title: Transdermal patch incorporating active agent migration barrier layer
Inventor: MILLER KENNETH J II
IPC: A61F13/02
Filed: 2004-01-26
Abstract: Devices (100) for administration of one or more active agents to the skin or mucosa of a host are formed in the nature of a double-disk patch (100).  One outer layer (110) functions as the primary adhesive layer for adhering the patch (100) to the host. The other inner layer (122) contains at least one active agent to be administered to the host. The inner layer (122) is bonded to the outer layer (110) through an opening (114) provided in an interposed active agent impermeable release layer (104). The release layer (104) separates a circumferential portion of the active agent containing inner layer (122) from the outer adhesive layer (220) to inhibit migration of the active agent therebetween.
Patent CA-2638866-A1 (CA)
Title: Inhibition a base de peptide d'une interaction de capcna dans un cancer
Inventor: HICKEY ROBERT J
IPC: C12N15/09
Filed: 2007-02-16
Abstract: L'invention concerne des peptides dérivés d'isoforme spécifique de cancer d'antigène nucléaire de cellules proliférantes (caPCNA, aussi connu comme csPCNA), ou de protéines interagissant avec nmPCNA, qui interférent avec une interaction protéine-protéine intracellulaire, en causant ainsi une réduction du potentiel prolifératif d'une cancer. Ces peptides servent de compositions thérapeutiques pour réduire la prolifération de cellules cancéreuses et aussi pour augmenter des méthodes chimiothérapeutiques existantes.
Patent CA-2641664-A1 (CA)
Inventor: HENDERSHOT REED JACOB
IPC: F23N1/00
Filed: 2008-10-23
Abstract: A burner system and method of operating a burner for reduced NOx emissions.  The burner system comprises a flame stabilizer, at least one fuel staging lance, an actuated valve, a temperature sensor and a controller. The amount of fuel to the flame stabilizer relative to the amount of fuel to the fuel staging lances is controlled depending on furnace temperature and/or furnace production rate.
Patent CA-2643573-A1 (CA)
Title: Solar air heater
Inventor: DOHERTY PAUL M
IPC: F24S10/70
Filed: 2007-02-26
Abstract: This invention provides novel devices and methods for the heating of air with solar radiant energy. The devices of the present invention feature a housing partitioned into essentially isolated sections wherein the sections are in fluid communication with each other through a plurality of channels located within the partitions. The two unique features of the invention, essentially isolated sections and partitions comprising a plurality of channels, increase the temperature achieved by the solar heater by 1) creating multiple, sequential sections that function independently of each other providing a higher starting temperature in each section and, therefore, a higher final temperature, 2) providing second means of heating the air within the channels located within the partitions and, 3) by virtually eliminating the mixing of incoming cold air with the heated air of the solar air heater.
Patent CA-2643617-A1 (CA)
Title: Aube metallique fabriquee par moulage et procede de fabrication de l'aube
Inventor: BAUMAS OLIVIER JEAN DANIEL
IPC: F01D11/02
Filed: 2008-11-06
Abstract: La présente invention concerne une aube de turbomachine formée par moulage, comportant une pale (4) à une extrémité de laquelle est ménagé un talon (5) formé d'une seule pièce avec la pale (4), dont il est solidaire au niveau d'une zone de raccordement (15), le talon (5) comportant une plate-forme (5a) sur laquelle est ménagée au moins une lame d'étanchéité (10, 11), une première baignoire (12) étant ménagée dans la plate-forme (5a), caractérisée par le fait qu'une seconde baignoire (16) est ménagée dans la première baignoire (12), au niveau de la zone (15) de raccordement entre la pale (4) et le talon (5).
Patent CA-2643667-A1 (CA)
Title: Process for contacting two phases whose contact is accompanied by heat evolution
Inventor: GROBYS MAURICIO
IPC: B01D53/14
Filed: 2007-03-16
Abstract: A method for bringing into contact two phases which are not completely miscible with one another, and whose contact is accompanied by heat development owing to mass transfer and/or chemical reaction, in which a first phase is introduced into the lower region of a contactor and a second phase is introduced into the upper region of the contactor and passed in countercurrent flow to the first phase in the contactor, a treated first phase and an exhausted second phase being obtained, which comprises recirculating a part of the exhausted second phase to the contactor at least one point situated between the upper region and the lower region. In the preferred embodiment, the first phase is a fluid stream comprising acid gases such as CO2, H2S, SO2, CS2, HCN, COS or mercaptans, and the second phase is an absorption medium which comprises an aqueous solution of at least one organic and/or inorganic base.
Patent CA-2644076-A1 (CA)
Inventor: CONSOLATI NICOLA
IPC: G01C21/26
Filed: 2007-03-08
Abstract: A system comprises an electronic device (20) with an anolog output which is connectable to an analog input amplifier (30) of a vehicle. A wireless standard first transceiver (21, 22) which can convert and send digital audio signals using digital audio streaming system to an analog audio output. A navigation device (10) with a wireless standard second transceiver (11, 12) can send together audio and voice instructions corresponding to a current navigation as digital audio signal using digital audio streaming.
Patent CA-2653451-A1 (CA)
Inventor: HARDAKER ELIZABETH LOUISE
IPC: C07H21/02
Filed: 2007-05-21
Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the IKK-B gene, comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the IKK-B gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression or activation of the IKK-B gene using the pharmaceutical composition; and methods for inhibiting the expression of the IKK-B gene in a cell.
Patent CA-2653781-A1 (CA)
Title: Stabilized insulin-like growth factor polypeptides
Inventor: FORNARO MARA
IPC: A61K38/30
Filed: 2007-06-06
Abstract: The invention relates to stabilized polypeptides having an IGF-I or IGF-2 sequence and an E-peptide sequence, where the natural physiological cleavage of the E-peptide from the IGF is prevented.
Patent CA-2655604-A1 (CA)
Title: Cyclopropyl amine derivatives
Inventor: BLACK LAWRENCE A
IPC: A61P25/00
Filed: 2007-06-22
Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
Patent CA-2656000-A1 (CA)
Inventor: LI LIANSHENG
IPC: A61K31/541
Filed: 2007-06-21
Abstract: The invention is directed to pyrro[l,2-b]pyridazinone compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.
Patent CA-2656175-A1 (CA)
Inventor: PELLEGRINO-GENSEY J LEE
IPC: C12N5/0735
Filed: 2007-06-26
Abstract: The present invention relates to the field of pluripotent stem cell cultu re media and to methods for culturing cells to produce such media-. Furtherm ore, the present invention provides methods and materials for propagating pl uripotent stem cells in a substantially undifferentiated state, with and wit hout a feeder layer. Conditioned medium for the propagation of pluripotent s tem cells is produced by a method comprising the steps of : a. Culturing cel ls that supply the conditioning factors, e.g. amniotic fluid cells or cells isolated from umbilical cord tissue, b. Adding a base medium to the cells th at supply the conditioning factors, c. Exposing the base medium to the cells that supply the conditioning -factors for a period of time sufficient to co ndition the medium, and d. Removing the conditioned medium.
Patent CA-2657711-A1 (CA)
Title: Methods for producing fuels and solvents
Inventor: BRESSLER DAVID
IPC: C10G3/00
Filed: 2007-07-12
Abstract: Described herein are methods for producing fuels and solvents from fatty acid resources. Also disclosed herein are fuels and solvents produced by the methods described herein.
Patent CA-2659220-A1 (CA)
Title: Method for establishing a detachable mechanical and/or electrical connection
Inventor: JAKOB ANDREAS
IPC: H04R25/00
Filed: 2001-03-13
Abstract: There is provided an hearing aid system and a method for establishing an electrical connection to a or in a hearing aid apparatus. The method comprises establishing the electrical connection via a series capacitor, thereby exploiting a part of the hearing aid apparatus' casing as dielectricum of the capacitor.
Patent CA-2659392-A1 (CA)
Title: Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
Inventor: HAGEMAN GREGORY S
IPC: A61K31/7105
Filed: 2007-07-13
Abstract: Disclosed are screening methods for determining a human subject's propensity to develop a vascular disorder and/or age-related macular degeneration (AMD), therapeutic or prophylactic compounds for treating disease or inhibiting its development, and methods of treating patients to alleviate symptoms of the disease, prevent or delay its onset, or inhibit its progression. The inventions are based on the discovery that persons with a genome having a deletion of the CFHR-1 and/or CFHR-3 gene, which normally lie on human chromosome 1 between DNA encoding CFH and CFHR-4, are at reduced risk of developing AMD, and elevated risk of developing vascular disease such as aneurysm.
Patent CA-2659890-A1 (CA)
Inventor: WEBSTER LESLEY
IPC: D21C9/00
Filed: 2007-07-31
Abstract: A mouldable paper pulp composition comprising an aqueous suspension of a base material comprising paper particles and a detergent resistant binding agent for the paper particles, in an intimate and substantially homogenous mix. Also provided are articles moulded from the composition.
Patent CA-2660201-A1 (CA)
Title: Organic compounds
Inventor: DALES NATALIE
IPC: C07D417/14
Filed: 2007-08-13
Abstract: The present invention provides heterocyclic derivatives that modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase and pharmaceutical compositions comprising such derivatives are also encompassed.
Patent CA-2662102-A1 (CA)
Title: Adsorption carrier containing composite fiber
Inventor: SHIMAGAKI MASAAKI
IPC: B01J20/26
Filed: 2007-08-30
Abstract: Disclosed is an adsorption carrier which can remove a cell occurring in the blood, preferably an activated leukocyte such as a granulocyte or a monocyte or a cancer cell, more preferably a cytokine present in an excessive amount, and which has a significantly increased cytokine-adsorbing ability compared to a conventional technique. The adsorption carrier comprises a fiber A having a diameter of 0.5 to 8 µm inclusive and a fiber B having a diameter of 8 to 50 µm inclusive, wherein the diameter of the fiber B is larger than that of the fiber A, and the fiber B comprises a sheath-core-type or island-sea-type composite fiber.
Patent CA-2664971-A1 (CA)
Inventor: HU LIANG
IPC: C01B32/50
Filed: 2009-04-30
Abstract: An improved process for deacidizing a gaseous mixture using phase enhanced gas-liquid absorption is described. The process utilizes a multiphasic absorbent that absorbs an acid gas at increased rate and leads to reduced overall energy costs for the deacidizing operation.
Patent CA-2666188-A1 (CA)
Title: Method and apparatus for diagnosing age-related macular degeneration
Inventor: WEBER BERNHARD H F
IPC: C07H21/00
Filed: 2009-05-19
Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing age-related macular degeneration comprising detecting an insertion/deletion polymorphism in the ARMS2 gene.
Patent CA-2666692-A1 (CA)
Title: Display apparatus, display method
Inventor: TSURUTA MASAAKI
IPC: G09G5/14
Filed: 2007-10-12
Abstract: Display control that extends a user's visual ability is accomplished. By wearing an eyeglass-type or headgear-type mounting unit, he or she is allowed to see display means disposed in front of his or her eyes.  By causing a part of a screen area of the display means to be in a through-state and a display with a display image signal to be executed, the user can see an image of a scene different from a scene that he or she ordinarily sees with a display of the display image signal while he or she can see the ordinary visual scene with the through-state area.
Patent CA-2669217-A1 (CA)
Title: Mutant .delta.8 desaturase genes engineered by targeted mutagenesis and their use in making polyunsaturated fatty acids
Inventor: ZHU QUINN QUN
IPC: C12N9/12
Filed: 2007-12-05
Abstract: The present invention relates to mutant .DELTA.8 desaturase genes, which have the ability to convert eicosadienoic acid [20:2 .omega.-6, EDA] to dihomo-.gamma.-linolenic acid [20:3, DGLA] and/or eicosatrienoic acid [20:3 .omega.-3, ETrA] to eicosatetraenoic acid [20:3 .omega.-3, ETA]. Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding .DELTA.8 desaturase along with methods of making long-chain polyunsaturated fatty acids (PUFAs) using these mutant .DELTA.8 desaturases in plants and oleaginous yeast are disclosed.
Patent CA-2670424-A1 (CA)
Inventor: SAITO HIDEFUMI
IPC: A61M16/06
Filed: 2006-11-28
Abstract: In supplying conditioned air in an airplane, conditioned air in which at least one of oxygen concentration and humidity has been regulated is produce d in the airplane. The produced conditioned air is blown out through a plura lity of air blowout ports (40a) disposed within a cabin in the airplane so a s to reach a face position region of a passengers H in each of a plurality o f seating positions within the cabin.
Patent CA-2670578-A1 (CA)
Inventor: MOGNA LUCA
IPC: A61K35/745
Filed: 2007-11-12
Abstract: The present invention relates to a composition for the administration of biologically active substances in a gynaecologic and rectal ambit, as well as the uses of said composition. Said composition presents particularly favourable technological and stability characteristics of the end product, above all with regard to the viscosity after the dissolution/resuspension of the same in a hydrophilic liquid medium which allows a better adhesion and a direct contact from bacteria to the treated mucosae. Said composition includes a specific viscosizing agent selected from the group of the gums, which can play an important prebiotic function by contributing in a significant way to the correct growth and colonization of the probiotic culture, thus forming a perfect symbiotic system.
Patent CA-2672207-A1 (CA)
Title: Methods and compositions for repelling arthropods
Inventor: BERNIER ULRICH R
IPC: A61K31/445
Filed: 2007-12-20
Abstract: A method for repelling arthropods involving treating an object or area with an arthropod repelling effective amount of at least one compound having the formula wherein X is O, S, NH, N-NH2, N-CH3 or CH2, R' is H or alkyl, R" is alkyl, n is 0, 1, 2, 3 or 4, and mixtures thereof, optionally including a earner material or earner. The compound is preferably selected from homopiperazine, 1-methylhomopiperazine, 1-methylpyrrolidine, (R)- (-)-2-methylpiperazine, (S)-(+)-2-methylpiperazine, 2-methylpiperazine, 1 -methylpiperazine, pyrrolidine, 1-methylpiperidine, piperidine, 1-ethylpiperazine, 1-methylimidazolidine, 1- methylthiomorpholine, 1,4-dimethylpiperazine, homopiperidine, imidazolidine, 4- methylpiperidine, thiomo.phi.holine, l-amino-4-methylpiperazine, 4-methylmoipholine, azocane, 2,6-dimethylpiperazine, 2,5-dimethylpiperazine, piperazine, 1-methylhomopiperidine, or mixtures thereof.
Patent CA-2672426-A1 (CA)
Title: Regularisation of irregularly sampled seismic data
Inventor: OEZDEMIR AHMED KEMAL
IPC: G01V1/36
Filed: 2007-10-15
Abstract: There is provided a method of spatially shifting seismic signals acquired through a seismic survey using the steps of identifying within the signals a set of N actual locations of seismic receivers and corresponding N seismic signals received by the set of seismic receivers; identifying a set of N' desired locations of seismic receivers; and determining a set of N' signal values at said N' desired locations by evaluating for each of said N' signal values a weighted sum of the N seismic signals, wherein the weights are at least partly determined by the relative distance between pairs of locations selected from said set of N actual locations of seismic receivers.
Patent CA-2678363-A1 (CA)
Title: Drug resistance reversal in neoplastic disease
Inventor: PATIL GHANSHYAM
IPC: A61K31/445
Filed: 2008-02-15
Abstract: The present invention is directed to compounds, compositions, and methods for halting or reversing the effects of chemoresistance in neoplastic diseases. In particular the use of hydroxylamines is described.
Patent CA-2678455-A1 (CA)
Title: Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
Inventor: ROGERS TRUE L
IPC: A61K9/14
Filed: 2008-01-10
Abstract: The present invention includes compositions and methods for making and using a rapid dissolving, high potency, substantially amorphous nanostructured aggregate for pulmonary delivery of tacrolimus and a stabilizer matrix comprising, optionally, a polymeric or non- polymeric surfactant, a polymeric or non-polymeric saccharide or both, wherein the aggregate comprises a surface area greater than 5 m2/g as measured by BET analysis and exhibiting supersaturation for at least 0.5 hours when 11-15-times the aqueous crystalline solubility of tacrolimus is added to simulated lung fluid.
Patent CA-2680953-A1 (CA)
Title: Communication systems and methods
Inventor: JURECKI MICHAEL
IPC: H04L12/16
Filed: 2009-09-29
Abstract: Systems and methods for communicating a financing application from a retailer to a finance source are provided. In some embodiments, information related to a financing application may be communicated from a retailer. The information may be converted to a suitable file format and automatically transmitted, for example, as a facsimile (or any other suitable file format) over communications paths using a communications network. In some embodiments of the present invention, motor vehicle dealership financing application techniques are used to determine financing eligibility, financing terms, or any combination thereof in connection with the sale or leasing of motor vehicles.
Patent CA-2681341-A1 (CA)
Title: Apoptotic anti-ige antibodies
Inventor: WU LAWREN
IPC: A61P37/06
Filed: 2008-03-21
Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
Patent CA-2681500-A1 (CA)
Title: Antibacterial compositions comprising an extract from arceuthobium
Inventor: FRIEDMAN CYNTHIA ROSS
IPC: A01P1/00
Filed: 2008-04-18
Abstract: This application relates to an antibacterial composition comprising an extract from a plant belonging to the genus Arceuthobium, such as Arceuthobium americanum. The composition may be used in a pharmaceutical composition or a disinfectant. The invention also relates to a method of treating or preventing a bacterial infection, the method comprising administering to a patient a composition comprising the extract.
Patent CA-2682528-A1 (CA)
Inventor: FENLON DEREK
IPC: G06M1/04
Filed: 2008-04-01
Abstract: The present invention relates to a metered dose inhaler dose counter, the counter comprising: an actuator; a rotary gear wheel having a plurality of ratchet teeth; a driver for driving the rotary gear in a step-wise fashion in response to displacement of the actuator; a pawl that prevents reverse rotation of the rotary gear; and a display coupled to the rotary gear.
Patent CA-2682579-A1 (CA)
Inventor: TZONG FU LIN
IPC: E06B9/326
Filed: 2009-10-14
Abstract: A window covering includes a plurality of lift cords extending from an upper rail and window covering material connected to the upper rail or the lift cords. A plurality of safety devices are attached to the window covering. Each safety device includes a male member and a female member. One of the members is attached to a respective lift cord and the other of the members is attached to a portion of the window covering material or a lower rail. The male and female members are configured to be attached together such that the male and female members separate from each other when a release force acts on at least one of the male member and female member.
Patent CA-2683505-A1 (CA)
Inventor: HANSEN HOLGER
IPC: B60N2/30
Filed: 2008-04-17
Abstract: The invention relates to a safety seat for land, air, and sea vehicles having a seat part fixed on two vertical retaining belts, each extending in the region of the rear seat part edge and attached to the vehicle, characterized in that each retaining belt (15) is designed as a belt sling (22) having a front belt (23) facing the seat part (17), the sling being stretched between anchors (16) fixed to the vehicle at a vertical distance from each other, and a rear belt (24) extending at a distance thereto, and that the seat part (17) is fixed in the intermediate space between the front belt (23) and rear belt (24) in a stationary closed fixed loop (27) attached to the rear belt (24) on one side, and is supported on the other side in a loose loop (28) attached to the rear belt (24).
Patent CA-2683852-A1 (CA)
Inventor: PETERSEN ANDERS KLARSKOV
IPC: A01N43/64
Filed: 2008-04-09
Abstract: Novel substituted benzamide based inhibitors, their use in therapy, pharmaceutical compositions comprising the compounds, the use of said compounds in the manufacture of medicaments, and therapeutic methods comprising the administration of said compounds are described. The present compounds modulate the activity of 11.beta. -hydroxysteroid dehydrogenase type 1 (11.beta.HSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, such as the metabolic syndrome.
Patent CA-2683993-A1 (CA)
Inventor: MANSFIELD TODD LEON
IPC: B32B25/10
Filed: 2007-04-24
Abstract: A stretch laminate includes a first layer including an elastomer film, the first layer having a surface, and a second layer including a nonwoven material, the second laye r having a surface that is attached to the surface of the first layer. The tensile behavior in the transverse direction of the stretch laminate is within about 2.5 N/cm of the tensile behavior in the transverse direction of the film at an engineering strain of about 1.5, and exists independent of mechanical activation. A method of making the stretch laminate and an absorbent article having at lea st one region defined by the stretch laminate are also provided.